The U.S. Government’s Vaccine Adverse Events Reporting System (VAERS) database was updated this past Friday, February 11, 2022, and it is now reporting that there have been 1,103,893 cases of injuries and deaths following COVID-19 vaccine since December of 2020, when the FDA issued emergency use authorizations for the COVID-19 vaccines. (Source.)
By way of contrast, there were 918,856 cases of injuries and deaths following all FDA-approved vaccines for the previous 30+ years, from 1990 through November of 2020. (Source.)
So there have been more injuries and deaths recorded in VAERS during the past 14 months following COVID-19 vaccines, than there were for the previous 30+ years combined following all vaccines recorded in VAERS.
Fetal Deaths Increase by 1,867% Following COVID-19 Vaccines

This most recent update of VAERS shows that there have now been 3,573 fetal deaths following COVID-19 vaccines. (Source.)
To arrive at the number of fetal deaths recorded in VAERS I had to test several different searches on listed “symptoms” and then see if the search results documented fetal deaths, since there is no demographic for “fetal deaths.”
The following is the current list of “symptoms” in VAERS that reveals fetal deaths:
- Aborted pregnancy
- Abortion
- Abortion complete
- Abortion complicated
- Abortion early
- Abortion incomplete
- Abortion induced
- Abortion induced incomplete
- Abortion late
- Abortion missed
- Abortion of ectopic pregnancy
- Abortion spontaneous
- Abortion spontaneous complete
- Abortion spontaneous incomplete
- Ectopic pregnancy
- Ectopic pregnancy termination
- Ectopic pregnancy with contraceptive device
- Foetal cardiac arrest
- Foetal death
- Premature baby death
- Premature delivery
- Ruptured ectopic pregnancy
- Stillbirth
This list may not be exhaustive. But if we use the exact same search using these symptoms, we can compare “apples to apples” in examining fetal deaths following COVID-19 vaccines as compared to fetal deaths following all non-COVID vaccines.
Using this search for all FDA-approved vaccines for the previous 30+ years before the COVID-19 vaccines were given emergency use authorization in December of 2020, we find 2,519 fetal deaths, the vast majority of which followed vaccines produced by Merck, which would include the Gardasil vaccines. (Source.)
Here are the yearly averages:
- 82 fetal deaths per year following non-COVID vaccines
- 3063 fetal deaths per year following COVID-19 vaccines
I arrived at these averages by taking the total number of fetal deaths following non-COVID vaccines and divided by 31, and for the fetal deaths following COVID-19 vaccines I divided by 14 to get the monthly average, and then multiplied by 12.
To get a more accurate percentage of how many more fetal deaths are following the COVID-19 vaccines than all other FDA approved vaccines, we have to also factor in the number of doses administered.
The U.S. Government’s Health Resources and Services Administration (HRSA) complies data on the National Vaccine Injury Compensation Program, and a report that they published on 12/01/2021 shows that there were over 4 billion (4,092,757,049) doses of vaccines administered in the United States between 1/01/2006 through 12/31/2019, a year before the COVID-19 vaccines were given emergency use authorizations. (Source.)
Using that date range I repeated the exact same search for fetal deaths recorded in VAERS during that time, and VAERS reports 1,369 deaths from among those 4 billion+ doses administered between 1/01/2006 through 12/31/2019. (Source.)
The CDC reported this past week that there have been 543 million doses of COVID-19 vaccines administered as of February 3, 2022. (Source.)
So from 2006 through 2019, there was 1 fetal death recorded in VAERS for every 2,989,596 doses of vaccines administered.
From December, 2020 through February 4, 2022, there has been 1 fetal death recorded in VAERS for ever 151,973 doses of COVID-19 vaccines administered.
That’s a 1,867% increase of fetal deaths recorded in VAERS following COVID-19 vaccines.
I’ve run out of superlatives to use in the English language to describe this. And this is just using the U.S. Government’s own reported statistics, without even trying to figure out what the unreported factor is.
Here are two recent stories from young mothers who lost their unborn babies just after receiving a second COVID-19 vaccine. Perhaps their words and their experiences, which obviously represent, at least, many thousands of others, can better communicate just how truly horrible this is.
This is on our Bitchute channel, and also on our Telegram channel.
February 13, 2022
Posted by aletho |
War Crimes | COVID-19 Vaccine, FDA, United States |
1 Comment
February 9, 2022
VIA FEDERAL EXPRESS and EMAIL
Dear Dr. Janet Woodcock:
We write to you on behalf of Children’s Health Defense (CHD), a non-profit organization devoted to the health of people and the planet. We have actively followed your work to evaluate, authorize and approve vaccines for the American public, and particularly children.
We are aware that you are likely to grant Emergency Use Authorization (EUA) of Pfizer’s BioNTech SARS-CoV-2 vaccine for children aged six months up to five years old following your upcoming meeting on February 15, 2022. We are writing to put you on notice that should you recommend this pediatric EUA vaccine to children under five years old, CHD is poised to take legal action against you. CHD will seek to hold you accountable for recklessly endangering this population with a product that has little, no, or even negative net efficacy but which may put them, without warning, at risk of many adverse health consequences, including heart damage, stroke and other thrombotic events and reproductive harms.
We briefly outline why such a recommendation would be reckless for nearly 20 million children in the United States, and millions more around the world.
-
There is no COVID emergency for children under five years old. Children have a 99.995% recovery rate and a body of medical literature indicates that almost zero healthy children under five years old have died from COVID.
-
A large study conducted in Germany showed zero deaths for children under 5 and a case fatality rate of three out of a million in children without comorbidities.
-
A Johns Hopkins study monitoring 48,000 children diagnosed with COVID showed a zero mortality rate in children under 18 without comorbidities.,
-
A study in Nature demonstrated that children under 18 with no comorbidities have virtually no risk of death.
-
Data from England and Wales, published by the UK Office of National Statistics on January 17, 2022 revealed that throughout 2020 and 2021, only one (1) child under the age of 5, without comorbidities, had died from COVID in the two countries, whose total population is 60 million.
-
Another study in Nature from April, suggests children’s bodies clear the virus more easily than adults.
-
This study published in December in Nature demonstrated how children efficiently mount effective, robust and sustained immune responses.
-
Over one third of all children are estimated to have natural immunity to COVID, according to CDC’s own data. There is no ethical justification for superfluous vaccination that will put children at elevated risk of vaccine harm.
-
The risks demonstrably outweigh the benefits of COVID vaccination in young children. A study out of Hong Kong, showed one out of every 2,700 12-17 year old boys being diagnosed with myocarditis following the 2nd dose of Comirnaty vaccine, or 37 per 100,000 vaccinated. A study from Kaiser found the same rate of myocarditis in 12-17 year old American boys, 1/2700.
-
While the CDC is saying that myocarditis is a mild disease, cardiologists know otherwise. CDC’s own preliminary data, reported at the February 4 ACIP meeting, revealed that nearly half of the young people diagnosed with myocarditis still had symptoms 3 months later, and 39% had their activity restricted by their physician. We know this serious adverse event occurs frequently in teenagers. But no one knows how often it occurs in younger children. This is of major concern for babies and younger children.
5. The clinical trials for children 2 through 4 years old failed., You’re proposing to use a product and schedule that failed in its clinical trials, and you may potentially add a third dose later in the spring. This is an unprecedented proposal not backed by science. It does not meet the risk-benefit standard of 21 U.S. Code § 360bbb–3 “the known and potential benefits of the product, when used to diagnose, prevent, or treat such disease or condition, outweigh the known and potential risks of the product.”
6. Some children likely will die and others will be permanently injured from these vaccines based on reporting to the current VAERS database. The latest data shows a total of 1,088,560 reports of adverse events from all age groups following COVID vaccines, including 23,149 deaths and 183,311 serious injuries between Dec. 14, 2020, and Jan. 28, 2022.
7. The pediatric clinical trials for the COVID vaccines were too small to detect safety signals–especially for a population in the tens of millions.
8. There are a) no long-term safety data for COVID vaccination of young children, and b) the proposal is to vaccinate children under the Emergency Use Authorization. Both a) and b) establish that vaccinating small children for COVID will be an experiment, not a standard medical procedure.
9. Unethical coercive pressure will be applied to children and their parents, as has occurred with older children and adults. To grant authorization is to abet this unethical coercion that violates the Nuremberg Code’s first principle.
10. There is no available care for children injured by COVID shots. There is no way to remove the spike protein and other toxic byproducts of vaccination, which may be produced for a considerable period of time following inoculation of messenger RNA. The science and medicine have not yet developed, and most families will be unable to cover the costs of potential catastrophic injuries.
11. First, do no harm. You are a physician who owes a duty to patients and medical ethics. If you recommend these shots to this age group, given all you know, will you be upholding your oath? If not, is it possible that your acts could later be seen as reason to remove your medical licenses?
12. The liability-free nature of your deliberations may not stand the test of time. In the fullness of time, your decisions may not have the liability protection that they currently enjoy. Under the PREP Act of 2005, all actors advancing an EUA agenda for medical countermeasures enjoy liability protection, absent willful misconduct., Nonetheless, if at a later point these shots are deemed non-therapeutic gene products that you knowingly and recklessly recommended, and which were then distributed to children as a direct result of your decision, it is possible that liability could later attach.
13. There are safer drugs that could be used prophylactically and therapeutically for COVID in children. There is extensive and compelling medical evidence for this assertion; and the choice to eschew use of these drugs in favor of a demonstrably dangerous vaccine is arbitrary and capricious.
14. The vaccines do not prevent transmission. They do not prevent infection. There is no statistically valid evidence that they prevent severe disease or deaths in children. Which begs the question: what are you actually trying to accomplish by vaccinating small children? What is your goal?
15. On August 23, 2021, FDA’s letter to BioNTech explained that neither the VAERS nor the VSD surveillance systems were adequate for FDA to determine the risk of myocarditis resulting from the Pfizer vaccine. Therefore, Pfizer and BioNTech were instructed by FDA to carry out a series of studies of myocarditis to ascertain the risk in different groups, including children. These studies were scheduled to produce final reports to FDA over the next five years. If the FDA is willing to wait until 2027 to learn the actual risks of myocarditis from the vaccine for children, shouldn’t it be required to wait until 2027 before inoculating millions of small children with a vaccine anticipated to provide them no benefit and possibly substantial risks?
16. An important Cell article in press, written by scientists from Stanford, has shown that, based on lymph node sampling after mRNA vaccination, spike protein and its mRNA remain present in the germinal centers of draining lymph nodes for up to 60 days, which is when sampling ceased. This was not supposed to happen. The demonstration of vastly prolonged spike protein production has revealed that the dose of spike protein produced in vivo by mRNA vaccines is unpredictable. FDA, however, requires uniformity of dosing. This fact alone should disqualify all authorizations and approvals of mRNA COVID vaccines.
We ask that you carefully consider all the information above before making any recommendation for Pfizer’s vaccine in the 6 months to under 5 year age group at your meeting on February 15, 2022.

_____________________________________
Robert F. Kennedy, Jr. Meryl Nass, M.D.
Unfortunately, the footnotes are missing from this version. They can be found at:
https://childrenshealthdefense.org/wp-content/uploads/CHD-Letter-to-FDA__EUA-Under-5_2-9-2022-1.pdf
February 13, 2022
Posted by aletho |
Science and Pseudo-Science, War Crimes | COVID-19 Vaccine, FDA, United States |
Leave a comment
On December 17, 2021, Pfizer announced that the clinical trial of its mRNA shot in kids under age 5 had failed. Rather than withdraw this product, Pfizer “amended” its clinical trial to add a third dose. So Pfizer kept the original trial going and subjected these little kids to yet another shot of genetically modified mRNA.
The drug dealers at the FDA said, ‘sounds great, let’s proceed with authorization even in the absence of data.’ That created a huge public backlash as parents rightly protested that the FDA should not approve a drug for kids that failed in a clinical trial.
Yesterday (Feb. 11, 2022), the FDA was forced to admit defeat and Pfizer pulled its Emergency Use Authorization (EUA) application to inject kids under age 5.
Pfizer and the FDA claimed that they were “waiting for more data” that would be available in early April. We now know that this was a lie.
Buried deep in an article on page A13 of the NY Times this morning we learned the real reason why Pfizer withdrew its EUA — the clinical trial had failed, again.
Remember, Pfizer kept the clinical trial going after December 17. So between then and yesterday’s announcement, there was now roughly 55 more days worth of data. And it was truly terrible.
From the NY Times :
Then, late on Thursday [Feb. 10], Pfizer alerted the F.D.A. that it had more recent data, from mid-January on, showing a more discouraging picture as the Omicron variant bore down. The new data revealed that two doses were not sufficiently effective in preventing symptomatic infection.
Read that again. They have the data. And the data show that this shot does not work.
But even here, I think there is reason to believe that they are still lying. We already knew that “two doses were not sufficiently effective” — Pfizer announced that in December. The “more recent data, from mid-January on” is not the two dose regimen anymore, that phase of the trial is finished.
I think there is every reason to believe that this is now the three dose trial that they are describing. If the three dose trial was on track and showing promising results, they would have proceeded with authorization. So now we likely have the first evidence that the three dose trial has failed as well.
(Here’s my math: Pfizer likely injected the third dose into these kids between Dec. 17 and mid-January. So “from mid-January on” (to Feb. 10) is looking at the data in the 25 days after the third injection. In the comments, please let me know if you interpret this differently.)
So it is definitely NOT the case that this is just an incomplete trial that they are waiting to finish up in early April. All of the existing data is bad. Pfizer is now scrambling to find ways to save this product even though the clinical trial has now failed twice. And what’s Pfizer’s plan going forward — to just hope that the data in the next 60 days (from now through early April) magically turns the corner!? Talk about wishful thinking!
Just when I think the cartel and its enablers in the mainstream media could not possibly get any more cynical they sink to new lows.
Janet Woodcock and Peter Marks at the FDA must be fired and prosecuted for reckless endangerment of children. Pfizer must stop this grotesque clinical trial immediately and permanently suspend any plans to inject genetically modified mRNA into children under 5. Anything less is savagery and barbarism.
February 12, 2022
Posted by aletho |
Deception, Science and Pseudo-Science, War Crimes | COVID-19 Vaccine, FDA, Janet Woodcock, Peter Marks, Pfizer, United States |
1 Comment
The U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) did it again.
The FDA last week granted its seal of approval for a ghost vaccine that is unavailable in the United States — and it did so using a preordained process that made a mockery of “science” and of “regulation.”
Days later, the CDC backed the FDA’s decision, using similarly flawed data and reasoning.
The approval of Moderna’s Spikevax COVID-19 vaccine was an even greater travesty than the FDA’s approval last August of Pfizer’s Comirnaty shot.
That’s because Moderna has been even more secretive than Pfizer about its trial data, and because Moderna’s shot is linked to an even higher rate of heart disease than Pfizer’s.
The FDA’s approval of the Pfizer Comirnaty vaccine led people to believe they would get a fully licensed, FDA-approved vaccine — when in fact they were still getting the Pfizer-BioNTech vaccine distributed under Emergency Use Authorization (EUA).
People can ask for the Comirnaty vaccine as often as they like — but it is not being distributed in the U.S. The Comirnaty vaccine is supposed to be the same formulation as the old Pfizer-BioNTech vaccine, but the vials labeled “Comirnaty” are in a legal class of their own.
Why this Kabuki theater?
Because any adult who is harmed or killed as a side effect of an “FDA-approved” vaccine can sue the manufacturer. But if you are harmed in exactly the same way by an EUA vaccine, you are out of luck — the manufacturer and everyone in the chain of delivery has full immunity from lawsuits. The law depends on the label.
Now Moderna has the same legal advantage as Pfizer. Its “Spikevax” is the same formula as the old Moderna vaccine, but only if you are dosed with a vial bearing the “Spikevax” label can you sue for bodily harm. So, of course, the Moderna vaccine continues to be distributed, but Spikevax is not available in the U.S.
The approval of Spikevax is not just a legal sham. It’s also a scientific sham. FDA approval is supposed to include long-term safety testing, but there is no long-term data available for a product that has been in existence less than a year.
The FDA hearings on the licensing of Spikevax were one-sided and dominated by self-congratulatory rhetoric. They also raised more questions than answers.
Questions for the FDA
- Besides offering publicity to the manufacturer and sowing confusion in the public mind, why would the manufacturers want FDA approval for a vaccine that is not available in the U.S.?
- Neither Pfizer nor Moderna explicitly specified the content of their placebos, but a published review claims they were simple saline. If this is the case, why is the rate of medical problems following injection with a “placebo” so much higher with Moderna’s placebo compared to Pfizer’s placebo?
For example, 18 people out of 15,000 in the Moderna placebo group died before the start of the trial (2 weeks from the second vaccination), while only 4 people out of 22,000 who received Pfizer’s placebo dose died in a comparable period. There were 31 “severe adverse events” in the placebo group of the Moderna trial, and zero in the (larger) Pfizer placebo group. What was in that “placebo” that killed 18 people and sent 31 to the hospital?
- The FDA relies on the Vaccines and Related Biological Products Advisory Committee (VRBPAC) to help assess the safety of vaccines before approval. There was an animated debate at the VRBPAC meeting for the Pfizer vaccine. Why was VRBPAC not invited to convene for the Moderna vaccine? The answer is given in this letter of approval from the FDA to Moderna (January 31, 2022):
“We did not refer your application to the Vaccines and Related Biological Products Advisory Committee because our review of information submitted in your BLA [Biologics License Application], including the clinical study design and trial results, did not raise concerns or controversial issues that would have benefited from an advisory committee discussion.”
- The FDA plainly states that it limited the scope of its analysis to the trial data alone. Why isn’t the FDA interested in the enormous amount of data that has become available in the last year?
Safety: Did FDA cook the books?
Deaths and disabilities associated with the mRNA “vaccines” have occurred with shocking frequency, 90 times as many as the worst vaccine in the past. There have been more than 1 million COVID vaccine reactions reported to the Vaccine Adverse Event Reporting System (VAERS), compared to 11,000 for the worst vaccine in 2020 (Shingrix).
There were more than twice as many deaths related to the COVID vaccines this year as the sum total of all vaccine deaths in the 30-year history of VAERS.
To rig the approval process in favor of such a product, the FDA needed to rewrite the rule book. The agency did this with a new statistical criterion, masking murder with mathematics. I am grateful to Matthew Crawford for having decoded the algebra and sounded the alarm.
The safety criterion chosen by the FDA is an obscure computation called PRR, which stands for Proportional Reporting Ratio. As the name implies, it is based on RATIOS of different event types and is utterly blind to the ABSOLUTE RATE of such events.
PRR measures the distribution of different kinds of adverse events, e.g. blood clots, heart attacks and deaths. If those ratios are severely out of line with the great variety of vaccine reactions in the past, PRR would detect that.
For example, if the new vaccines caused an extraordinary risk of myocarditis, but everything else was low, then PRR would flag that. But if myocarditis was just one risk among many that have been reported from past vaccines, then PRR would not pick that up.
The real scandal is that PRR is blind to the absolute risk numbers. PRR is defined in such a way as to look for unusual PATTERNS of adverse events, but it is completely insensitive to unusual RATES of adverse events.
Of course, it is the rates and not the patterns that are of primary concern, and the PRR is designed NOT to reflect that.
For example, suppose we have two vaccines:
- Vaccine A has 1 reported death per million vaccinations, 3 reported heart attacks per million, and 20 reported headaches per million.
- Vaccine B has 1 reported death per hundred vaccinations, 3 reported heart attacks per hundred, and 20 reported headaches per hundred.
Vaccine A is quite safe, and vaccine B is extremely dangerous. And yet the formula for PRR will produce the same result for vaccine A and B!
Clearly, PRR is not an appropriate criterion for evaluating the safety of any particular vaccine. Did the FDA use PRR in order to cook the books?
In Moderna’s own trials, 1.3% of vaccine recipients had a reaction to the vaccine that was severe enough to require medical attention. The following possible side effects were listed in information given to doctors:
“Anaphylaxis and other severe allergic reactions, myocarditis, pericarditis, and syncope have been reported following administration of the Moderna COVID-19 Vaccine during mass vaccination outside of clinical trials.”
Off with his head! — the CDC’s ACIP hearings
In Alice’s Wonderland, the Red Queen’s justice began with the execution, then there was a verdict — and finally a trial.
The FDA hearing was followed by a meeting of the Advisory Committee on Immunization Practices (ACIP), which reports to the CDC.
The committee on Feb. 4 voted to recommend the Moderna Spikevax. Only after that action step had been secured did the committee hear testimony from the Public Health Agency of Canada that Moderna’s vaccine was associated with a myocarditis risk five times higher than Pfizer’s.
Questions for the CDC
- All-cause mortality was equal in both placebo and vaccine groups (16 deaths in each). In the midst of a pandemic, Moderna’s vaccine demonstrated no survival benefit. This should have been enough to end any further consideration of approval.
- We have detailed data on myocarditis from decades of past history. One-fourth of myocarditis patients are dead within 5 years, but the same study reports that if the myocarditis is caused by human immunodeficiency virus, then three-fourths die in the same 5 years.
We have no long-term data on vaccine-induced myocarditis, but we do have some 6-month data, which show 39% of cases still had their activity restricted by their doctors, 20% were still on heart medication, 32% still reported chest pain, 22% still had shortness of breath, 22% had palpitations and 25% still reported fatigue. Thirteen vaccine recipients died. (All these numbers were presented at the ACIP hearing on Feb. 4.)
Why should we have confidence that the course of vaccine-induced myocarditis will be much less severe than other forms of the disease?
- The Moderna trial, like the Pfizer trial, was limited to healthy people, mostly young, with no pre-existing problems. Pregnant women were explicitly excluded. Why is the vaccine being approved as safe for everyone, including diabetics and immune-compromised, elderly and pregnant women?
- When mRNA vaccines were approved on an emergency basis, the FDA promised to track all safety concerns with a new cell phone app called V-Safe. Why are the results of V-Safe being withheld from the public?
- The FDA was considering approval of Moderna’s vaccine in January 2022. There was a full year’s experience with side effects reported from nearly 200 million doses of the Moderna vaccine in the U.S. alone. But the FDA limited its consideration to the 15,000 subjects who were in the Moderna trial, ending March 26, 2021. Why was this huge trove of data on vaccine safety not reviewed by the FDA?
- Yes, we understand that the vaccine doesn’t become fully effective until 2 weeks after the second shot. But is that a reason to exclude from consideration the damage that is inflicted by enhanced vulnerability to disease during those two weeks, or, for that matter, the four weeks between shots? These have been counted as diseases of the “unvaccinated,” but in fact, people in this stage of treatment are much more vulnerable than the truly unvaccinated.
- France and Germany do not recommend Moderna’s vaccination for young people, presumably because the Moderna vaccine is associated with a higher rate of myocarditis than the Pfizer vaccine. How did our FDA come to a different conclusion?
- Anaphylaxis following vaccination is an immediate, life-threatening and an undeniable consequence of the vaccine. The CDC claimed the rate of anaphylaxis is 6 per 1 million.
However, in March of 2021, an examination of anaphylaxis following mRNA vaccines revealed a much higher incidence of this adverse event. In fact, 9 of 38,971 Moderna vaccine recipients suffered documented anaphylaxis. This equates to 230 per million, or 38 times higher than the CDC estimate.
Efficacy — but at what cost?
The proper measure of the efficacy of any medication is how it affects all aspects of a patient’s health. But in evaluating the Moderna vaccine, the FDA looked only at its effect on COVID.
There are early but disturbing indications that vaccination worldwide has had dramatic effects on other aspects of health, unrelated to COVID. Insurance company trade journals report that they are paying life insurance claims for adults 18-64 years of age at a rate 40% higher than during any normal year.
This number from OneAmerica (Indianapolis) has been echoed by other studies in Europe. A leaked spreadsheet from the Defense Medical Epidemiological Database showed that incidences of many medical problems in the U.S. military surged in this year of vaccination. For example, heart attacks were up 343%, cancers up 218%, among many other disorders.
Could it be that the vaccines have had a small benefit for COVID severity and disastrous impact on other aspects of human health?
We now have some real-world experience with the efficacy of vaccines. For example, we know the virus mutated to a more contagious, less lethal form. Omicron is now the dominant form of the virus in the U.S. and most other parts of the world today.
The Omicron mutations are concentrated in the spike protein — the only part of the virus to which the vaccinated population has immunity. This suggests the virus is mutating in response to the vaccine, and mutations are an important factor affecting efficacy in the long run.
Nevertheless, the FDA considered efficacy data predominantly from the first five months of data (through March 26, 2021) in making its decision to fully license Spikevax, with an absolute cutoff in November, before Omicron became dominant.
More questions
- Almost all subjects in the original Moderna trial who received placebo initially were subsequently given the vaccine. How will we ever know the long-term effects of the vaccine if we have no controls with which to compare?
- Why do CDC studies of death rates based on vaccination status differ so markedly from the same question asked by independent groups in other countries?
Here, for example, is a report from Public Health Scotland stating that vaccination increases vulnerability to Omicron. Here is a similar report from England. This study shows countries with higher vaccination rates tend to have higher rates of COVID, and this one confirms the same result for U.S. states.
- We are now in an era dominated by the Omicron variant, against which all the vaccines seem much less effective. But even “follow-up data” was analyzed only through March 26, 2021, nine months before Omicron took over. Why did the FDA base its decision on data only from older variants?
- The secondary efficacy endpoint was the prevention of severe COVID-19. Now that it is accepted that there is little, if any, protective effect of mRNA vaccines from infection, the prevention of severe disease should be the primary focus of approval determination.
Moderna claims its vaccine efficacy is an astonishing 98.2% in preventing severe COVID-19 (Table 8). Pfizer’s was 96.7% (Table S6).
The reason for the calculated difference in efficacy between these two products was not from a lower incidence of severe disease in the vaccine arm of Moderna’s trial (it was lower in Pfizer’s trial). It was because the incidence of severe disease in Moderna’s placebo group was much higher than in Pfizer’s.
Severe COVID-19 in Pfizer’s placebo group occurred in 30 participants out of 23,0379. In Moderna’s, severe disease occurred in 106 participants out of 14,164 that received a placebo. Why was the incidence of severe COVID-19 nearly six times higher in Moderna’s placebo group than Pfizer’s?
Postscript: Failure was never an option
In America, why are clinical trials for new drugs run by the same companies that own the drugs, and will profit from them if the trial is successful?
It’s a glaring conflict of interest, but necessary within a capitalist system. Since the trials cost, typically, hundreds of millions of dollars, only the company that will profit from the drug is motivated to invest such huge sums in testing.
In the case of the COVID vaccines, however, the development and the trials were both publicly funded. There was no excuse for contracting the same organization both to develop and test their own product.
Moderna’s development cost was funded through Operation Warp Speed in the U.S. and Pfizer through the German government. Now, the companies are reaping windfall profits, though they risked no money of their own.
This leaves us wondering, did our government ever want a fair and unbiased evaluation of the COVID vaccines? Or — after a full year of telling the public that vaccines were the only path out of the COVID crisis — did NIH feel they could not risk the possibility that the trials might fail?
There were no animal tests. There was no time to experimentally optimize dosage and delivery. They had to guess right the first time.
Maybe they thought this is what the exigency of a pandemic required — but please don’t call it “science.”
Josh Mitteldorf, Ph.D., has a background in theoretical physics. Since the 1990s, he is best known for his contributions to the biology of aging, including many articles and two books.
© 2022 Children’s Health Defense, Inc. This work is reproduced and distributed with the permission of Children’s Health Defense, Inc. Want to learn more from Children’s Health Defense? Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. Your donation will help to support us in our efforts.
February 10, 2022
Posted by aletho |
Corruption, Deception, Science and Pseudo-Science, Timeless or most popular | CDC, COVID-19 Vaccine, FDA, United States |
1 Comment
A federal judge Wednesday rejected a bid by the U.S. Food and Drug Administration (FDA), with the support of Pfizer, to delay the court-ordered release of nearly 400,000 pages of documents pertaining to the approval of Pfizer’s COVID vaccine.
Federal judge Mark Pittman of the U.S. District Court for the Northern District of Texas, in an order issued Feb. 2, said the FDA must release redacted versions of the documents in question according to the following disclosure schedule:
- 10,000 pages apiece, due on or before March 1 and April 1, 2022.
- 80,000 pages apiece, to be produced on or before May 2, June 1 and July 1, 2022.
- 70,000 pages to be produced on or before Aug. 1, 2022.
- 55,000 pages per month, on or before the first business day of each month thereafter, until the release of the documents has been completed.
The order grants the FDA the ability to “bank” excess pages as part of this release schedule — meaning that if the agency exceeds its monthly quota in any given month it can apply those extra pages to a subsequent month.
Last week’s ruling is the most recent development in an ongoing court case that began with a Freedom of Information Act (FOIA) request filed in August 2021 by Public Health and Medical Professionals for Transparency (PHMPT), a group of doctors and public health professionals.
PHMPT, a group of more than 30 medical and public health professionals and scientists from institutions such as Harvard, Yale, and UCLA, in September 2021 filed a lawsuit against the FDA after the agency denied its original FOIA request.
In that request, PHMPT asked the FDA to release “all data and information for the Pfizer vaccine,” including safety and effectiveness data, adverse reaction reports, and a list of active and inactive ingredients.
The FDA argued it didn’t have enough staff to process the redaction and release of hundreds of thousands of pages of documents, claiming it could process only 500 pages per month.
This would have meant the cache of documents would not be fully released for approximately 75 years.
In his Jan. 6 order, Pittmann rejected the FDA’s claim and instead required the agency to release 12,000 pages of documents by Jan. 31 and an additional 55,000 pages per month thereafter.
Pfizer responded, to the Jan. 6 order by filing a memorandum with the court on Jan. 21, requesting to intervene in the case for the “limited purpose of ensuring that information exempt from disclosure under FOIA is adequately protected as FDA complies with this Court’s order.”
Pfizer claimed to support the disclosure of the documents, but asked to intervene in the case to ensure that information legally exempt from disclosure will not be “disclosed inappropriately.”
As reported by The Defender, this request, if granted, would have also meant further delay for the release of the next tranche of documents, until May 1.
Lawyers for PHMPT, in a brief submitted Jan. 25, asked Pittman to reject Pfizer’s motion, prompting Pittman’s Feb. 2 order.
The first batch of documents produced in Nov. 2021, which totaled a mere 500 pages, revealed there were more than 1,200 vaccine-related deaths within the first 90 days following the release of the Pfizer-BioNTech COVID vaccine.
Michael Nevradakis, Ph.D., is an independent journalist and researcher based in Athens, Greece.
© [Article Date] Children’s Health Defense, Inc. This work is reproduced and distributed with the permission of Children’s Health Defense, Inc. Want to learn more from Children’s Health Defense? Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. Your donation will help to support us in our efforts.
February 7, 2022
Posted by aletho |
Deception, Science and Pseudo-Science | COVID-19 Vaccine, FDA, United States |
1 Comment
The U.S. Food and Drug Administration (FDA) on Monday granted full approval of Moderna’s Spikevax COVID vaccine for people 18 and older.
Similar to the agency’s licensing last year of Pfizer’s Comirnaty vaccine, the approval raised a number of legal questions related to mandates and product availability.
Spikevax is a two-dose primary series, approved also for administration as part of a heterologous (“mix and match”) single booster dose for individuals who previously completed their original series of vaccinations with the Pfizer or Johnson & Johnson COVID vaccines.
According to the FDA, Spikevax “has the same formulation as the [Emergency Use Authorization (EUA)] Moderna COVID-19 Vaccine and … can be used interchangeably with the EUA Moderna COVID-19 Vaccine to provide the COVID-19 vaccination series.”
However, in its approval letter, the FDA said Spikevax is “legally distinct” from the Moderna EUA vaccine:
“The licensed vaccine has the same formulation as the EUA-authorized vaccine and the products can be used interchangeably to provide the vaccination series without presenting any safety or effectiveness concerns. The products are legally distinct with certain differences that do not impact safety or effectiveness.”
The FDA made the same distinction between the Pfizer-BioNTech EUA vaccine and the Pfizer Comirnaty vaccine, which the agency fully licensed in August, 2021, a move that raised questions about liability and the legality of vaccine mandates.
After Monday’s announcement, media outlets were quick to reassure the public the two Moderna vaccines are the same and that this was just a marketing ploy, where Moderna simply “rebranded” what is otherwise the same vaccine.
No ‘fully licensed’ COVID actually available
While Moderna’s Spikevax vaccine is now fully licensed, the original Moderna vaccine will remain under EUA. Indeed, the FDA on Jan. 7 reissued the EUA.
The FDA has also made it clear the Spikevax vaccine will not be available to the American public, announcing:
“Although SPIKEVAX (COVID-19 Vaccine, mRNA) and Comirnaty (COVID-19 Vaccine, mRNA) are approved to prevent COVID-19 in certain individuals within the scope of the Moderna COVID-19 Vaccine authorization, there is not sufficient approved vaccine available for distribution to this population in its entirety at the time of reissuance of this EUA.”
These claims parallel the chain of events that followed the FDA’s full approval of the Pfizer Comirnaty vaccine in August 2021.
At the time, Pfizer and the FDA claimed Comirnaty was not yet available, as there were sufficient stocks of the Pfizer-BioNTech EUA vaccine still available to be administered.
As of this writing, the FDA states, via its website, that Comirnaty products are “not orderable at this time.”
The FDA has not indicated when, or if, the Spikevax and Comirnaty vaccines will be available for distribution in the U.S.
Are EUA and fully licensed vaccines really interchangeable?
As reported by The Defender, there is a significant legal distinction between products authorized under EUA and those fully licensed by the FDA.
EUA products are experimental under U.S. law. Under the Nuremberg Code and federal regulations, no one can force a human being to participate in this experiment.
Specifically, under 21 U.S. Code Sec.360bbb-3(e)(1)(A)(ii)(III), “authorization for medical products for use in emergencies,” it is unlawful to deny someone a job or an education because they refuse to be an experimental subject. Instead, potential recipients have an absolute right to refuse EUA vaccines.
That’s an issue military members, unable to find any vaccination sites that offer the fully licensed Comirnaty vaccine, cited in various lawsuits challenging vaccine mandates.
Notably, on Nov. 12, 2021, a federal judge rejected an argument by the U.S. Department of Defense, in defending the military’s vaccine mandate, that the Pfizer Comirnaty and Pfizer-BioNTech vaccines are “interchangeable.”
U.S. law also requires the EUA designation be used only when “there is no adequate, approved and available alternative to the product for diagnosing, preventing or treating such disease or condition.”
This means that, in legal terms, all EUA products should be withdrawn once alternative products have received full approval.
Perhaps the most significant legal distinction, however, pertains to the legal protections afforded vaccine manufacturers, depending on how their product is classified.
Under the 2005 Public Readiness and Preparedness (PREP) Act, EUA-approved vaccines enjoy a significant liability shield. Specifically, vaccine manufacturers, distributors, providers, and government officials involved in the policymaking, approval, and distribution process are immune from any legal liability.
Under such regulations, the only way an injured party can sue is if he or she can prove willful misconduct, and if the U.S. government has also brought an enforcement action against the party for willful misconduct.
No such lawsuit has ever succeeded.
Conversely, fully licensed vaccines, such as Spikevax and Comirnaty, do not have a liability shield, and are instead subject to the same product liability laws as other products.
This means the Spikevax and Comirnaty vaccines could expose pharmaceutical companies to significant financial claims if individuals injured by the vaccines chose to sue the vaccine makers.
The rush to get COVID vaccines authorized for all ages — a ploy to avoid liability?
There’s another reason Pfizer and Moderna don’t want their fully licensed vaccines to be available yet — they’re waiting for the vaccines to be authorized, then licensed, for children as young as 6 months old.
Why? Because once a vaccine is fully licensed by the FDA, the only way its manufacturer can be shielded from legal liability is if the vaccine is added to the Centers for Disease Control and Prevention’s childhood vaccination schedule.
The National Childhood Vaccine Injury Act (NCVIA), passed into law in 1986, provides a legal liability shield to drugmakers if they receive full authorization for all ages and the vaccine is added to the mandatory schedule.
Reporting on the FDA’s approval of Spikevax, investigative journalist Jordan Schachtel wrote:
“Are Pfizer and Moderna waiting for full authorization for children’s shots to distribute Comirnaty and Spikevax to the masses? There’s plenty of litigators who have suggested that this is exactly what is going on in Big Pharma world.”
By creating the public perception that the Pfizer and Moderna EUA vaccines are fully approved, businesses, schools and other institutions are emboldened to impose vaccine mandates that violate existing law and allow the vaccines to be administered without informed consent.
It has also been argued that by relabeling the product, any previous data regarding vaccine injuries and side effects identified in association with the EUA vaccine are not counted in the safety studies for the approved vaccine.
The FDA approval of the Pfizer Comirnaty vaccine, its subsequent lack of availability and the continued administration of the Pfizer-BioNTech EUA vaccine led Children’s Health Defense (CHD) to file a lawsuit against the FDA and its acting director, Dr. Janet Woodcock, for their allegedly deceptive and rushed approval of the Comirnaty vaccine, arguing that the approval represented a classic “bait and switch” tactic.
CHD further alleged in its lawsuit that the FDA violated federal law when it simultaneously licensed Pfizer’s Comirnaty vaccine and extended Pfizer’s EUA — as the agency has now done with Moderna and Spikevax — for a vaccine that has the “same formulation” and that “can be used interchangeably,” according to the FDA.
FDA admits no safety data for Spikevax use among pregnant women
Beyond the legal questions raised by the FDA’s approval this week of Spikevax, the approval also raises safety questions.
For instance, the FDA admitted Spikevax was insufficiently tested on pregnant women, stating that “[a]vailable data on SPIKEVAX administered to pregnant women are insufficient to inform vaccine-associated risks in pregnancy.”
Furthermore, Spikevax was approved without having been tested for its ability to provide protection against the Omicron variant, which is reported to account for 99.9% of current U.S. COVID cases — it was approved only for providing protection against mutations that are no longer circulating.
And yet, the FDA cited the Omicron variant as the reason behind its decision to pull its EUA for monoclonal antibody products. The FDA claims that these products have not been shown to provide protection against the Omicron variant.
Michael Nevradakis, Ph.D., is an independent journalist and researcher based in Athens, Greece.
© 2022 Children’s Health Defense, Inc. This work is reproduced and distributed with the permission of Children’s Health Defense, Inc. Want to learn more from Children’s Health Defense? Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. Your donation will help to support us in our efforts.
February 3, 2022
Posted by aletho |
Deception, Timeless or most popular, War Crimes | COVID-19 Vaccine, FDA, Moderna, Pfizer, Spikevax, United States |
Leave a comment
Days prior to today’s scheduled release of a tranche of documents related to the Pfizer COVID vaccine, the pharmaceutical company asked a federal court to let it intervene before any information is released.
It’s the latest development in an ongoing court case that began with a Freedom of Information Act (FOIA) request filed in August 2021 by Public Health and Medical Professionals for Transparency (PHMPT).
PHMPT asked the U.S. Food and Drug Administration (FDA) to release all documents related to its Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID vaccine and full approval of the Pfizer-Comirnaty COVID vaccine.
Judge Mark Pittman of the U.S. District Court for the Northern District of Texas on Jan. 6 issued an order requiring the FDA to release 12,000 pages of documents by Jan. 31 and an additional 55,000 pages per month thereafter, until the release of the nearly 400,000 pages of documents is complete.
Pfizer claims to support the disclosure of the documents, but asked to intervene in the case to ensure that information exempt from disclosure will not be “disclosed inappropriately.”
In a memorandum it submitted to the court, Pfizer said it:
“[S]eeks leave to intervene in this action for the limited purpose of ensuring that information exempt from disclosure under FOIA is adequately protected as FDA complies with this Court’s order.”
Attorneys for Pfizer also claimed while it was not asking the court to reconsider the Jan. 6 order, it would consider challenging the order at an unspecified later date, telling the court:
“Pfizer does not presently intend to move the Court to reconsider its January 6, 2022 order, but Pfizer is not in a position at this time to waive its ability to do so if circumstances change such that there is good cause at a later time to do so.”
Pfizer did not clarify what such a change of circumstances might entail.
Lawyers for PHMPT, in a brief submitted Jan. 25 to the court, asked Pittman to reject Pfizer’s motion and requested the judge ask Pfizer to clarify how, exactly, its intervention would help expedite the release of the documents, arguing that Pfizer:
“… provides no reason why it needs to intervene in this matter to render that purported assistance. Nor can Plaintiff discern why Pfizer needs to intervene in this matter to assist the FDA with expediting release of the requested documents—it can render this assistance without intervening.”
PHMPT, a group of more than 30 medical and public health professionals and scientists from institutions such as Harvard, Yale, and UCLA, in September 2021 filed a lawsuit against the FDA when the agency denied its original FOIA request.
In that request, PHMPT asked the FDA to release “all data and information for the Pfizer vaccine,” including safety and effectiveness data, adverse reaction reports, and a list of active and inactive ingredients.
The first batch of documents released in November 2021, which totaled a mere 500 pages, revealed there were more than 1,200 vaccine-related deaths within the first 90 days following the release of the Pfizer-BioNTech COVID vaccine.
Arguments regarding Pfizer’s motion are scheduled to be heard in court on Jan. 28, though as of this writing, no further updates regarding the case or this scheduled hearing have been publicly disclosed.
Pfizer represented by world’s third-largest law firm
Pfizer on Jan. 21 submitted two filings to the court: a motion to intervene in the case “for a limited purpose,” and an accompanying “memorandum of points and authorities” supporting the motion.
It remains unclear how Pfizer defines “inappropriately” or “for a limited purpose,” or why it waited two weeks after Judge Pittman’s order, and only days before the Jan. 31 scheduled release of 12,000 pages to file its motion.
Pfizer claims it was unaware of the case until executives read news reports about it in December 2021, despite the fact that the case garnered coverage from major news outlets, including Reuters, in November of that year.
Still, the company hired DLA Piper LLP, one of the world’s most high-powered law firms, to represent it. DLA Piper is headquartered in London and maintains offices in 40 countries.
In 2014, the firm had revenues totaling $2.48 billion, making it the third-largest law firm in the U.S. by revenue.
DLA Piper was the 12th largest donor to President Obama’s 2012 re-election campaign and the 9th largest donor to Hillary Clinton between 1999 and 2018.
Douglas Emhoff, spouse of U.S. Vice President Kamala Harris, was employed at the firm until 2020, earning $1.2 million in partnership income that year.
FDA supports Pfizer’s motion, requests extension
In a response to Pfizer’s motion, the FDA said it welcomed Pfizer’s “help,” claiming that this is “due to the unprecedented speed with which the Court has ordered [the] FDA to process the records at issue.”
In addition to supporting Pfizer’s motion, the FDA also requested an extension from the court that would further delay the scheduled release of the documents.
Aaron Siri of the Siri & Glimstad law firm, who is representing PHMPT in its lawsuit against the FDA, explained:
“The FDA now insists it must delay its first 55,000-page production until May 1, 2022 – four months after the Court entered its order.
“However, the FDA’s own papers seeking this delay make plain it can produce at a rate of 55,000 pages per month in February and March.”
The FDA claimed Pfizer is entitled to intervene in the case and the process of redacting the documents in question, due to the “Trade Secrets Act,” signed into law by President Obama in 2016, stating:
“FDA anticipates that coordination with Pfizer to obtain the company’s views as to which portions of the records are subject to Exemption 4, the Trade Secrets Act, 18 U.S.C. § 1905, or other statutory protections will be a necessary component of the agency’s endeavors to meet the extraordinary exigencies of this case.”
However, according to The Gateway Pundit, the Trade Secrets Act is being misinterpreted by the FDA and Pfizer:
“[T]he protections provided under that law allow for an owner of a trade secret to sue in federal court when its trade secrets have been misappropriated and does not even imply that a company could intervene in a public records request through the FOIA.”
PHMPT, in its Jan. 25 brief, also rejected the FDA’s continued claim that it cannot adhere to the disclosure schedule Pittman ordered on Jan. 6, arguing “the FDA has more than sufficient resources to expeditiously produce the requested documents.”
Siri, on his blog, also questioned this aspect of FDA’s argument, writing:
“The FDA … attests that over the coming weeks, it will have 28.5 full-time people reviewing the documents. Working 7.5 hours per day for 20 business days per month, 28.5 people reviewing 50 pages per hour can review a total of approximately 213,750 pages per month.
“The FDA affirms it has already ‘allocated the equivalent of nearly 11 full-time staff to this project’ and that ‘a review speed of 50 documents per hour was within the normal range for document review in a complex matter’ in private practice; and here the 50 document per hour rate would be faster since there is only a need to review for personally identifying information (‘PII’) for most pages. Hence, if the FDA’s 11 full-time reviewers work only 7.5 hours per day and review 50 pages (not documents) per hour, the FDA could review over 88,000 pages per month in February and March. That is more than sufficient to produce the 55,000 pages per month currently ordered for these two months.”
Instead of complying with this court’s “reasoned order,” Siri Wrote, the FDA claims these 11 reviewers can only review a total of 10,000 pages per month.
What the FDA does not say, and what basic math shows, according to Siri, is that a rate of 10,000 pages a month for 11 full-time reviewers amounts to only 5 pages per hour.
Siri also questioned the FDA’s commitment to transparency and hinted at a cover-up, stating:
“The Court is, other than Congress, the only check on the FDA. In a free country, transparency is paramount, and the FDA has chosen to thwart transparency and the requirements of FOIA by anemically understaffing the office it maintains to respond to FOIA requests.
“It is also incredible for the FDA to claim that compliance here would harm its health policy objectives. Even if the FDA really does need to spend $4 to $5 million which … is an absurd overestimate, that is an inconsequential amount of its overall $3.41 billion discretionary budget.
“It is understandable that the FDA does not want independent scientists to review the documents it relied upon to license Pfizer’s vaccine given that it is not as effective as the FDA originally claimed, does not prevent transmission, does not prevent against certain emerging variants, can cause serious heart inflammation in younger individuals, and has numerous other undisputed safety issues.”
Siri said the FDA’s “potential embarrassment” over its decision to license the Pfizer vaccine must take a back seat to the transparency demanded by FOIA and “the urgent need and interests of the American people to review that licensure data.”
Michael Nevradakis, Ph.D., is an independent journalist and researcher based in Athens, Greece.
© 2022 Children’s Health Defense, Inc. This work is reproduced and distributed with the permission of Children’s Health Defense, Inc. Want to learn more from Children’s Health Defense? Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. Your donation will help to support us in our efforts.
BUY TODAY: Robert F. Kennedy, Jr.’s New Book — ‘The Real Anthony Fauci’
January 31, 2022
Posted by aletho |
Deception | Comirnaty, COVID-19 Vaccine, FDA, Pfizer, United States |
1 Comment
Pfizer and Moderna set to ask the FDA & CDC to grandfather in their reformulated coronavirus vaccines with almost no data
I just got another 30-day suspension from Facebook. It’s always interesting to see which posts set off the Stasi. The purpose of censorship is to delete any facts that contradict the Pharma narrative. So every time they censor one of my posts it tells me that this content was directly over the target.
Many of my previous suspensions were in the weeks leading up to key FDA and CDC decisions on mRNA vaccine applications. I was highly visible on social media sharing information about why the risks of these shots outweigh the benefits. It seems that Pfizer and Moderna just put out the word that they want to get the approval across the line and the Stasi get to work banning anyone with data or analysis that might hurt their application. They ban me about three weeks before the FDA/CDC decision, get the approval they seek, and then my suspension expires.
And that seems to be the case again here.
In this instance, Facebook suspended me for a post from two months ago. They never explain their decision and never point out any factual errors in my post. But ask yourself, why did this particular post trigger the Thought Police?
November 28, 2021
Guys and gals listen up. The battle ahead is this: both Pfizer and Moderna have announced plans to develop new multivalent mRNA shots within 100 days to address new variants. They will argue to the FDA and CDC that these new shots (now the fourth dose of a failed product) should be grandfathered in without further clinical trials because they are similar to the existing (deadly toxic junk) product. If that happens, then all future doses of this product, whatever the formulation, will never go through clinical trials of any kind.
I am hard-pressed to imagine a more apocalyptic scenario — injections, for most everyone in the developed world, every six months, forever, with no clinical trials, and no idea of what is in the vial. It’s a eugenicists’ dream.
We must begin pushing now to tell every elected official and every regulator that there must be new clinical trials or they will be prosecuted at Nuremberg 2.0.
Republicans hoping to take back the Congress in 2022 must be on record as demanding new clinical trials.
Existing trials are terrible but they give us a chance to see how these companies rig the data and they give us a point of comparison (to show that they lied) when real world data comes in. We have very little data on new variants but Pfizer and Moderna’s plans to proceed without clinical trials are a possible extinction-level event for humanity.
Updated to add: the message to elected officials has to be simple — Any new formulation needs a proper new clinical trial (50,000 participants, at least 2 years follow up, conducted by an independent 3rd party).
My assertions in this post are based on years of studying the Pharma playbook. Is there any evidence that anything I said in this post is incorrect? Pharma is going to try to get these reformulated coronavirus vaccines grandfathered in without further regulatory scrutiny.
To the extent that there are any clinical trials — they will be these sham trials like the recent third dose Emergency Use Authorization applications. As you will recall, the Moderna third dose “trial” had 149 participants in the treatment group and the Pfizer “trial” had 200 participants total. I wrote about that (here). These “trials” were so bad that the top two vaccine safety regulators at the FDA quit rather than approve this worthless toxic junk under political pressure from the Biden administration. Indeed these “trials” were so bad that the hand picked Yes-men (and women) on the Vaccines and Related Biological Products Advisory Committee rejected the applications (16 to 2) — so Janet Woodcock just pushed the applications through under her signature, against their advice.
The fact that FB censored this two-month old post out of the blue suggests that this is exactly what Pfizer and Moderna are about to do — they are going to bum-rush these reformulated coronavirus vaccines through the rotten FDA and CDC and start injecting them into billions of people with no data on safety or effectiveness.
These reformulated vaccines are ostensibly to address the Omicron variant — although a new variant will have already taken its place by the time these reformulated vaccines are available. So once again these vaccines are likely to have zero or negative efficacy against the virus and produce unknown levels of harm including iatrogenic injury and antibody dependent enhancement. The introduction of reformulated vaccines is also likely to accelerate the evolution of new variants.
This is why we need a revolution. This is why we must overthrow the existing regime. Common carriers and most bourgeois institutions in the U.S. work for the Cartel. And the Cartel is engaged in democide throughout the developed world because democide is very profitable and this is now their business model.
January 27, 2022
Posted by aletho |
Deception, Full Spectrum Dominance, Science and Pseudo-Science, War Crimes | CDC, COVID-19 Vaccine, Facebook, FDA |
1 Comment
In fact, I do have a personal life. My wife of of 42 years and I are actually pretty private. Sharing personal history is not something I do everyday. However, as many of you know – I was vaccinated with Moderna twice and had a pretty significant vaccine injury. This was pretty early in the roll-out of the vaccines. It was long before the FOIA Japanese pre-clinical trial data that had so many red-flags and irregularities, long before we learned of all the issues with the clinical trials, and long before the VAERs and adverse events began to be known.
To write it, I have never been an “anti-vax” person. I have spent my career working with vaccines. I also know that some vaccines are “hot,” and are less safe. Usually these types of vaccines are reserved for extremely dangerous viruses like Ebola or Yellow fever. Where the goal is to make the vaccine 100% effective. Other vaccines, that are distributed widely, like the flu vaccines need to be very safe. The trade-off being that they are less effective. There is a whole science and art to crafting vaccines to appropriately respond to the “threat.” So, I know to read the literature, do my own due- diligence, etc before taking an experimental product or any vaccine. That is what I thought I did. The government assured us that these vaccines were very safe. I could never imagine that clinical data would be corrupted and even falsified – as we now know it was.
Anyway, back to my story. I knew in the beginning of April, 2021, that I had to travel overseas and the word on the street was that the European Union was going to require full vaccination before entering any EU country by summer (that actually never happened BTW). I knew that a full vaccination protocol was a process of weeks – and that i had better get started! Furthermore, there was a lot of buzz around the idea that vaccination would help with “long-COVID.” I had already had COVID, and just couldn’t shake a number of chronic issues that I had developed after getting the disease. Frankly, I should have done more homework on that one- because this idea really didn’t hold up to scrutiny.
Be that as it may, in April, 2021, I got vaccinated. It was early enough in the cycle, that I had no choice but to take the Moderna vaccine, as that was available in my area The vaccine was distributed at a local college, with the Army Reserves administering the program.
The first shot was fine. No issues.
The second shot almost did me in. As in I almost died.
After the injection, I had the usual fatigue, muscle-ache and then the palpitations started, as well as shortness of breath. Within a couple days, it got worse – I am not someone who goes to the doctor easily, but luckily for me, I happened to have a routine appointment with my physician. She cuffed me and my systolic blood pressure was through the roof. As she is also a cardiologist, she had more tests run, started me on high blood pressure meds and we got it under control. I kind of feel like I owe her my life. A call out to the fantastic Dr. C. Bove.
Fast forward to today.
One of the people who comments on my Substack articles, pointed me to this website:
https://www.howbadismybatch.com/
This site matches up vaccine batch codes with information from the VAERS system, which is the event reporting system run by the CDC. This site matches the vaccine batches to adverse drug reactions, death, disability and life threatening illnesses from the VAERS system
According to the website above, the data reported in VAERS, reproduced on the site, show that adverse events triggered by Moderna batches have varied widely.
- 5% of the batches appear to have produced 90% of the adverse reactions
- Some Moderna batches are associated with 50 x the number of deaths and disabilities compared to other batches.
With that knowledge, I entered my batch code in the search box. The first injection had almost no significant adverse events associated with it. The second jab, frankly shocked me
Here are the results:
Now, I don’t know how many doses are in each batch. But I do know my batch was most definitely in the top 5%. So, not really a surprise in retrospect that I had such a serious adverse event profile.
I always felt I was lucky that I happened to be going to my physician that day, who is also a cardiologist (she is my internist – so I wasn’t seeing her for that specialty).
But just think- our government had this data way back when in the VAERs system -even last summer. This data is so compelling and yet… crickets. How many people could they have helped by releasing this data? People like me, who if I wasn’t a physician and hadn’t gone to my physician could have easily dropped dead.
What is wrong with our government that a site like this is not available from the CDC or the FDA?
If anyone has any doubts about adverse events from these vaccines, take a look at some of the peer reviewed research or look at the VAERS data for deaths in young adults and children.
People have the right to be given informed consent of risks and benefits of a medical procedure. Informed consent is not given, if the risks are hidden.
WHERE THERE IS RISK, THERE MUST BE CHOICE
January 14, 2022
Posted by aletho |
Deception, Science and Pseudo-Science, Timeless or most popular | CDC, COVID-19 Vaccine, FDA, Human rights, United States |
8 Comments
COVID is a very treatable disease if it is treated early using an early treatment protocol. There are lots of such protocols that are highly successful. This new book documents one such protocol.
Since March of 2020, Brian Tyson and George Fareed, two physicians with impeccable credentials, have been treating COVID patients of all ages in Imperial Valley, CA using early treatment protocols.
Their track record is extraordinary. If you started treatment within 7 days of first symptoms, only 2 people were briefly hospitalized and there were no deaths. The earlier you start treatment, the better the results and the faster you recover.
Their book is now available at Amazon (if you buy it now on Kindle for $5.95, it will be delivered Jan 24). It is a #1 best seller as you can see below.

The entire pandemic response was unnecessary: COVID is very treatable if treated early
This book shows that we’ve known about effective treatments since March 2020.
Had the CDC publicized such treatments, it would have made the entire pandemic response completely unnecessary: lockdowns, vaccines, mandates, masking, business closures, etc. Everyone would have gotten natural immunity and the pandemic would have ended with virtually no deaths.
Tyson and Freed tried contacting the FDA, CDC, and NIH, but nobody would talk to them or return their calls. The same is true today. They are just “too busy” to talk to them. Keeping patients out of the hospital and morgue is not a priority for them.
The same is true of the mainstream media. The NY Times refused to run op-eds about early treatments and CNN said that they were too busy covering the vaccines and people dying from COVID that they didn’t have the resources to talk about early treatment protocols that would have prevented everything.
Instead of promoting early treatment using repurposed drugs, the CDC instructed people to just stay home and do nothing until they were so sick that they had to go to the hospital. Even after drugs in the Tyson/Fareed protocol like ivermectin and fluvoxamine have been proven time and time again to work in clinical trials and, in the case of ivermectin, published in systematic reviews and meta-analyses, the NIH still fails to acknowledge them rating them NEUTRAL. This means that most doctors will not use them.
On May 24, 2021, I offered $2M to anyone who could show that the NIH made the proper decision on these two drugs, but nobody came forward.
In short, nobody in the world thought they made the right decision (or at least could justify it). But they are the authorities and we cannot question their judgement, ever.
The CDC doesn’t want you to share this post with anyone
The CDC would like you to know the following:
- You need to follow our advice. Do not think. Do not ask questions. Just do as you’re told. We are the CDC and we always know best.
- Trust us: early treatments don’t work. Ignore all the data from these physicians. Even though we’ve never even talked to them or looked at their data, we know they are wrong. We don’t even have to look at their data to know that they are wrong. The data does not matter. It is our opinion that matters. Got it?
- Do not share this post with anyone, especially your doctor, anyone in mainstream media, or Congress. Do not to do anything to disrupt Big Pharma’s profits.
- Even if you did share it, nobody would believe you anyway; they will think you are crazy. We have totally brainwashed pretty much everyone except for a relatively small number of people.
- Don’t read the book. This book will destroy our credibility as well as that of the NIH and FDA. You may not be able to deal with the cognitive dissonance. Just do what we say. Don’t worry, be happy.
- If you feel you must read the book, ask your doctor to prescribe Versed and take it as directed before you read the book. That way, after you are done reading it, you won’t remember anything.
- If the public finds out about this book, a lot of people are going to be very upset about how they’ve been fooled. You wouldn’t want that to happen now, would you?
January 10, 2022
Posted by aletho |
Book Review, Full Spectrum Dominance, Mainstream Media, Warmongering, Science and Pseudo-Science, Timeless or most popular | CDC, Covid-19, FDA, New York Times, NIH |
1 Comment
The video above features Collette Martin, a practicing nurse who testified before a Louisiana Health and Welfare Committee hearing December 6, 2021.1,2 Martin claims she and her colleagues have witnessed “terrifying” reactions to the COVID shots among children — including blood clots, heart attacks, encephalopathy and arrhythmias — yet their concerns are simply dismissed.
Among elderly patients, she’s noticed an uptick in falls and acute onset of confusion “without any known etiology.” Coworkers are also experiencing side effects, such as vision and cardiovascular problems.
Martin points out that few doctors or nurses are aware the U.S. Vaccine Adverse Events Reporting System (VAERS) even exists, so injury reports are not being filed. Hospitals also are not gathering data on COVID jab injuries in any other ways, so there’s no data to investigate even if you wanted to. According to Martin:
“We are not just seeing severe acute [short term] reactions with this vaccine, but we have zero idea what any long-term reactions are. Cancers, autoimmune [disorders], infertility. We just don’t know.
We are potentially sacrificing our children for fear of MAYBE dying, getting sick of a virus — a virus with a 99% survival rate. As of now, we have more children that died from the COVID vaccine than COVID itself.
And then, for the Health Department to come out and say the new variant [Omicron] has all the side effects of the vaccine reactions we’re currently seeing — it’s maddening, and I don’t understand why more people don’t see it. I think they do, but they fear speaking out and, even worse, being fired … Which side of history will you be on? I have to know that this madness will stop.”
Martin also states she believes the hospital treatment protocol is killing COVID patients. Doctors agree that it’s “not working,” but that “it’s all we have.” But “that’s simply not true,” she says. “It’s just what the CDC will allow us to give.”
What the VAERS Data Tell Us About COVID Jab Risks
I recently interviewed Jessica Rose, Ph.D., a research fellow at the Institute for Pure and Applied Knowledge in Israel, about what the VAERS data tell us about the COVID jabs’ risks. As noted by Rose, the average number of adverse event reports following vaccination for the past 10 years has been about 39,000 annually, with an average of 155 deaths. That’s for all available vaccines combined.
The COVID jabs alone now account for 983,756 adverse event reports as of December 17, 2021, including 20,622 deaths3 — and this doesn’t include the underreporting factor, which we know is significant and likely ranges from five to 40 times higher than reported. Most doctors and nurses don’t even know what VAERS is and even if they do, they chose not to report the incidents.
You can’t even compare the COVID shots to other vaccines. They’re by far the most dangerous injections ever created, yet there doesn’t appear to be a cutoff for acceptable harm. No one within the CDC or Food and Drug Administration, which jointly run VAERS, has addressed these shocking numbers. Both agencies outrageously deny that a single death can be attributed to the COVID jabs, which is simply impossible. It’s not statistically plausible.
The FDA and CDC are also ignoring standard data analyses that can shed light on causation. It’s known as the Bradford Hill criteria — a set of 10 criteria that need to be satisfied in order to show strong evidence of causal relationship. One of the most important of these criteria is temporality, because one thing has to come before the other, and the shorter the duration between two events, the higher the likelihood of a causative effect.
Well, in the case of the COVID jabs, 50% of the deaths occur within 48 hours of injection. It’s simply not conceivable that 10,000 people died two days after their shot from something other than the shot. It cannot all be coincidence. Especially since so many of them are younger, with no underlying lethal conditions that threaten to take them out on any given day. A full 80% have died within one week of their jab, which is still incredibly close in terms of temporality.4
Children Risk Permanent Heart Damage
Aside from the immediate risk of death, children are also at risk for potentially lifelong health problems from the jab. Myocarditis (heart inflammation) has emerged as one of the most common problems, especially among boys and young men.
In early September 2021, Tracy Beth Hoeg and colleagues posted an analysis5 of VAERS data on the preprint server medRxiv, showing that more than 86% of the children aged 12 to 17 who report symptoms of myocarditis were severe enough to require hospitalization.
Cases of myocarditis explode after the second shot, Hoeg found, and disproportionally affect boys. A full 90% of post-jab myocarditis reports are males, and 85% of reports occurred after the second dose. According to Hoeg et. al.:6
“The estimated incidence of CAEs [cardiac adverse events] among boys aged 12-15 years following the second dose was 162 per million; the incidence among boys aged 16-17 years was 94 per million. The estimated incidence of CAEs among girls was 13 per million in both age groups.”
No doubt, doctors are seeing an increase in myocarditis, but few are willing to talk about it. In a recent Substack post, Steve Kirsch writes:7
“I just read a comment on my private ‘healthcare providers only’ substack. An estimated100X elevation in rate of myocarditis, but nobody will learn of it since cardiologists aren’t going to speak out for fear of retribution.
His comment was a private conversation he had with a pediatric cardiologist. The cardiologist is never going to say this in public, to the press, or have his name revealed since his first duty is to his family (keeping his job).
If a ‘fact checker’ called the cardiologist, he might either refuse to comment or say ‘I’m seeing somewhat more cases after the vaccine rolled out.’ Here’s the exact comment that was posted to the private substack:
‘Pre-jab, one or two cases per year of myocarditis. Now, half his waiting room. Tells parents they are ‘studying’ the causality. Refers them to infectious disease specialist for discussions on their other children.
Admits he and about 50% of his colleagues know what’s going on but are too terrified to speak out for fear of retaliation from hospitals and state licensing boards.
Other 50% don’t want to know, don’t care and/or are reveling in the cognitive dissonance (like Dr. Harvey [Cohen] at Stanford) and/or letting loose their authoritarian demon. Good luck with these former colleagues of mine. The stench is overpowering.’
… From 1 or 2 cases per year to ‘half his waiting room.’ I don’t know the size of his waiting room, but it’s at least two people since he said ‘half.’ So, the rate has increased by: 250 day per year open/1.5 avg cases per year=166X.”
Myocarditis Is Not a Mild, Inconsequential Side Effect
Together with Dr. Peter McCullough, in October 2021 Rose also submitted a paper8 on myocarditis cases in VAERS following the COVID jabs to the journal Current Problems in Cardiology. Everything was set for publication when, suddenly, the journal changed its mind and took it down.
You can still find the pre-proof on Rose’s website, though. The data clearly show that myocarditis is inversely correlated to age, so the risk gets higher the younger you are. The risk is also dose-dependent, with boys having a sixfold greater risk of myocarditis following the second dose.
While our health authorities are shrugging off this risk saying cases are “mild,” that’s a frightening lie. The damage to the heart is typically permanent, and the three- to five-year survival rate for myocarditis has historically ranged from 56% to 83%.9
Patients with acute fulminant myocarditis (characterized by severe left ventricular systolic dysfunction requiring drug therapy or mechanical circulatory support10) who survive the acute stage have a survival rate of 93% at 11 years, whereas those with acute nonfulminant myocarditis (left ventricular systolic dysfunction, but otherwise hemodynamically stable11) have a survival rate of just 45% at 11 years.12
This could mean that anywhere from 7% to 55% of the teens injured by these shots today might not survive into their late 20s or early 30s. Some might not even make it into their early 20s! How is this possibly an acceptable tradeoff for a virus you have practically zero risk of dying from as a child or adolescent?
Excess Deaths Are Exploding, Including Among Teens
Throughout the pandemic, the COVID jab was held out as the way back to normalcy. Yet, despite mass injections and boosters, excess deaths keep rising. For example, in the week ending November 12, 2021, the U.K. reported 2,047 more deaths13 than occurred during the same period between 2015 and 2019.
COVID-19 cannot be entirely to blame, as it was listed on the death certificates for only 1,197 people. Even more telling is the fact that, since July 2021, non-COVID deaths in the U.K. have been higher than the weekly average in the five years prior to the pandemic. Heart disease and strokes appear to be behind many of the excess deaths, and both are known side effects of the COVID jab.
In a November 28, 2021, Twitter post,14 Silicon Valley software engineer Ben M. (@USMortality) revealed that in the preceding 13 weeks, about 107,700 seniors died above the normal rate, despite a 98.7% vaccination rate. In another example, he used data from the CDC and census.gov to show excess deaths rising in Vermont even as the majority of adults have been injected.15
“Vermont had 71% of their entire population vaccinated by June 1, 2021,” he tweeted. “That’s 83% of their adult population, yet they are seeing the most excess deaths now since the pandemic!”
Even more disturbing, British data show deaths among teenagers have spiked since that age group became eligible for the COVID shots.16 Between the week ending June 26 and the week ending September 18, 2020, 148 deaths were reported among 15- to 19-year-olds. Between the week ending June 25, 2021, and the week ending September 17, 2021, 217 deaths occurred in that age group. That’s an increase of 47%!
Deaths from COVID-19 also went up among 15- to 19-year-olds after the shots were rolled out for this age group. Significant concerns have been raised about the possibility that COVID-19 vaccines could worsen COVID-19 disease via antibody-dependent enhancement (ADE).17 Is that what’s going on here? As reported by The Exposé, which conducted the investigation:18
“Correlation does not equal causation, but it is extremely concerning to see that deaths have increased by 47% among teens over the age of 15, and COVID-19 deaths have also increased among this age group since they started receiving the COVID-19 vaccine, and it is perhaps one coincidence too far.”
Omicron Poses No Risk to Young People
As noted in a recent analysis by Dr. Robert Malone,19 (who recently got banned from Twitter but can be found on Substack), the risk-benefit ratio of the COVID shot is becoming even more inverted with the emergence of Omicron, as this variant produces far milder illness than previous variants, putting children at even lower risk of hospitalization or death from infection than they were before, and their risk was already negligible.
Malone is currently spearheading the second Physicians Declaration20 by the International Alliance of Physicians and Medical Scientists, which has been signed by more than 16,000 doctors and scientists, stating that “healthy children shall not be subjected to forced vaccination” as their clinical risk from SARS-CoV-2 infection is negligible and long term safety of the shots cannot be determined prior to such policies being enacted.
Not only are children at high risk for severe adverse events from the shots, but having healthy, unvaccinated children in the population is crucial to achieving herd immunity.
Shots Double Risk of Acute Coronary Syndrome
Researchers have also found Pfizer and Moderna mRNA COVID-19 shots dramatically increase biomarkers associated with thrombosis, cardiomyopathy and other vascular events following injection.21
People who had received two doses of the mRNA jab more than doubled their five-year risk of acute coronary syndrome (ACS), the researchers found, driving it from an average of 11% to 25%. ACS is an umbrella term that includes not only heart attacks, but also a range of other conditions involving abruptly reduced blood flow to your heart. In a November 21, 2021, tweet, cardiologist Dr. Aseem Malhotra wrote:22
“Extraordinary, disturbing, upsetting. We now have evidence of a plausible biological mechanism of how mRNA vaccine may be contributing to increased cardiac events. The abstract is published in the highest impact cardiology journal so we must take these findings very seriously.”
AMA Is A-OK With Sacrificing Children
Tragically, it’s not only the CDC and FDA that have been captured by the drug industry and who are sacrificing public health, including the health of our children, in order to further the technocratic Great Reset agenda.
Even the American Medical Association, which is supposed to lobby for physicians and medical students in the U.S. and promote medicine for the betterment of public health, has abandoned all semblance of ethics, transparency and honesty.
In a mid-November 2021 article on the AMA’s website, “COVID-19 Vaccine for Kids: How We Know It’s Safe,”23 contributing news writer Tanya Albert Henry cites data straight from Pfizer’s press release, and then goes on to claim we “know it’s safe” because “younger children see the same side effects as has been seen in adults and teens.” Based on the VAERS data, that should send shivers down parents’ backs.
“The American Academy of Pediatrics is on board with vaccinating this age group, along with the American Academy of Family Physicians and the Pediatrics Infectious Diseases Society, said Dr. Fryhofer, chair-elect the AMA Board of Trustees,” Henry writes.
“Dr. Fryhofer … noted that myocarditis has been a rare occurrence after the second dose of the mRNA vaccines. ‘The observed risk is highest in young males age 12 to 29, but COVID infection can also cause myocarditis,’ she pointed out. ‘For adolescents and young adults, the risk of myocarditis caused by COVID infection is much higher than after mRNA vaccination.’”
Really? Where did Fryhofer get that idea? I’ve not seen any data to back that up, and Henry doesn’t provide any.
What Do the VAERS Data Show?
Research published in 201724 calculated the background rate of myocarditis in children and youth, showing it occurs at a rate of four cases per million per year. According to the U.S. Census Bureau, as of 2020 there were 73.1 million people under the age of 18 in the U.S.25 That means the background rate for myocarditis in adolescents (18 and younger) would be about 292 cases per year.
As of December 17, 2021, looking only at U.S. reports and excluding the international ones, VAERS had received:26
- 308 cases of myocarditis among 18-year-olds
- 252 cases among 17-year-olds
- 226 cases in 16-year-olds
- 256 cases in 15-year-olds
- 193 in 14-year-olds
- 132 in 13-year-olds
In total, that’s 1,475 cases of myocarditis in teens aged 18 and younger — five times the background rate. And again, this does not take into account the underreporting rate, which has been calculated to be anywhere from five to 40.
Meanwhile, the CDC27 claims that, between March 2020 and January 2021, “the risk for myocarditis was 0.146% among patients diagnosed with COVID-19,” compared to a background rate of 0.009% among patients who did not have a diagnosis of COVID-19.
After adjusting for “patient and hospital characteristics,” COVID-19 patients between the ages of 16 and 39 were on average seven times more likely to develop myocarditis than those without COVID.
That said, the CDC stressed that “Overall, myocarditis was uncommon” among all patients, COVID or not. What’s more, only 23.7% of myocarditis patients between the ages of 16 and 24 had a history of COVID-19, so a majority of the cases in that age group were not due to COVID.
We’re also not talking about big numbers in terms of actual COVID infections. The weekly adolescent hospitalization rate peaked at 2.1 per 100,000 in early January 2021, declined to 0.6 per 100,000 in mid-March, and rose to 1.3 per 100,000 in April.28
Using that peak hospitalization rate of 2.1 per 100,000 (or 21 per million) in this age group, and assuming the risk for myocarditis is 0.146% among COVID-positive patients, we get a myocarditis-from-COVID rate among adolescents of 0.03 per million. That’s a far cry from the normal background rate of four cases per million, so the risk of getting myocarditis from SARS-CoV-2 infection is probably quite small.
Now, assuming the COVID hospitalization rate for adolescents is 21 per million, and we have 73.1 million adolescents, we could expect there to be 1,535 hospitalizations for COVID in this age group in a year. If 0.146% of those 1,535 teens develop myocarditis, we could expect 2.2 cases of myocarditis to occur in this age group each year, among those who come down with COVID.
In summary, based on CDC statistics, we could expect just over two teens to contract myocarditis from COVID-19 infection. Meanwhile, we have 1,475 cases reported following the COVID jab in just six months (shots for 12- to 17-year-olds were authorized July 30, 202129).
Taking into account underreporting, the real number could be anywhere between 7,375 and 59,000 — again, in just six months! To estimate an annual rate, we’d have to double it, giving us anywhere from 14,750 to 118,000 cases of myocarditis. So, is it actually true that “For adolescents and young adults, the risk of myocarditis caused by COVID infection is much higher than after mRNA vaccination”? I doubt it.
Can You Lessen the Damaging Effects?
There is absolutely no medical rationale or justification for children and teens to get a COVID shot. It’s all risk and no gain. If for whatever reason your son or daughter has already received one or more jabs, and you hope to lessen their risk of cardiac and cardiovascular complications, there are a few basic strategies I would suggest implementing.
Keep in mind these suggestions DO NOT supersede or cancel out any medical advice they may receive from their pediatrician. These are really only recommendations for when there are no adverse symptoms. If your child experiences any symptoms of a cardiac or cardiovascular problem, seek immediate medical attention.
1. First and foremost, do not give them another shot or booster.
2. Measure their vitamin D level and make sure they take enough vitamin D orally and/or get sensible sun exposure to make sure their level is between 60 ng/mL and 80 ng/ml (150 to 200 nmol/l).
3. Eliminate all vegetable (seed) oils in their diet. This involves eliminating nearly all processed foods and most meals in restaurants unless you convince the chef to only cook with butter. Avoid any sauces or salad dressings as they are loaded with seed oils.
Also avoid conventionally raised chicken and pork as they are very high in linoleic acid, the omega-6 fat that is far too high in nearly everyone and contributes to oxidative stress that causes heart disease.
4. Consider giving them around 500 milligrams per day of NAC, as it helps prevent blood clots and is a precursor for the important antioxidant glutathione.
5. Consider fibrinolytic enzymes that digest the fibrin that leads to blood clots, strokes and pulmonary embolisms. The dose is typically two to six capsules, twice a day, but must be taken on an empty stomach, either an hour before or two hours after a meal. Otherwise, the enzymes will merely act as a digestive enzyme rather than digesting fibrin.
Sources and References
January 8, 2022
Posted by aletho |
Timeless or most popular, Video, War Crimes | AMA, American Academy of Pediatrics, CDC, COVID-19 Vaccine, FDA, United States |
Leave a comment
You must take this product. You cannot sue if injured. You can maybe see the clinical trial safety data in 75+ years. And the deidentified post-licensure safety data – no, you cannot see that either.
Three prior posts explained how the FDA seeks to delay for 75+ years full production of Pfizer’s pre-licensure safety data. While we have that fight, we submitted a request to the CDC, on behalf of ICAN, for the deidentified post-licensure safety data for the Covid-19 vaccines in the CDC’s v-safe system. Even though this data is available in deidentified form (meaning, it includes no personal health information), the CDC refused to produce this data claiming it is not deidentified.
So, on behalf of ICAN, we filed a federal lawsuit against the CDC and its parent entity, the U.S. Department of Health and Human Services (HHS), to force the CDC to produce this data to the public. The CDC should have no issue doing so because it has already made this data available to a private company – Oracle – in deidentified form. It is telling that Larry Ellison’s company can see the data American taxpayers paid the CDC to collect but the average American and independent scientists cannot?!
What is the v-safe system you may ask? Since rolling out the Covid-19 vaccines, the FDA and CDC have stated that their primary safety monitoring system, VAERS, is unreliable. The CDC therefore deployed a new safety monitoring system for COVID-19 vaccines called “v-safe.” V-safe is a smartphone app that allows vaccine recipients to “tell CDC about any side effects after getting the COVID-19 vaccine.” The purpose of the app “is to rapidly characterize the safety profile of COVID-19 vaccines when given outside a clinical trial setting.” With this new system, the CDC claims that these “vaccines are being administered under the most intensive vaccine safety monitoring effort in U.S. history.”
That all sounds great. And a CDC document explains that data submitted to v-safe is “collected, managed, and housed on a secure server by Oracle,” a private computer technology company, and that Oracle can access “aggregate deidentified data for reporting.” This means data submitted to v-safe is already available in deidentified form and could be immediately released to the public.
But yet, after we submitted a FOIA request to the CDC, on behalf of ICAN, to produce the deidentified v-safe data, the CDC acknowledged that “v-safe data contains approximately 119 million medical entries” but refused to produce that data by claiming that the “information in the app is not de-identified.” The CDC had apparently not read its own documentation regarding v-safe. But we had. So, we appealed this decision and submitted another request to the CDC that expressly asked only for any deidentified v-safe data, in the app or otherwise. Meaning, in the form that the CDC made the data available to Oracle. Incredibly, the CDC administratively closed this request stating it was duplicative of the original request.
Let me break that down again. The first request was denied by the CDC because it claimed the request sought data in the app that was deidentified. But then the CDC closed the second request, which made clear it is seeking only deidentified data (in the app or otherwise), by claiming the second request was duplicative of the first request! If this sounds ridiculous, it is because it is.
The public should be outraged by the CDC’s games.
The introduction to the lawsuit is copied below with a link to the entire complaint at the end. As with the pre-licensure Pfizer data, if you find what you are reading difficult to believe, that is because it is dystopian for the government to give pharmaceutical companies billions, mandate Americans to take their products, prohibit Americans from suing for harms, yet refuse to let Americans see the pre- and post-licensure safety data for these products. The lesson yet again is that civil and individual rights should never be contingent upon a medical procedure.
INTRODUCTION TO LAWSUIT AGAINST CDC FOR V-SAFE DATA
1. Between December 2020 and February 2021, the Food and Drug Administration (“FDA”) issued Emergency Use Authorizations for three COVID-19 vaccines, one of which subsequently received FDA approval in August 2021. While the FDA approved these vaccines, the Centers for Disease Control and Prevention (“CDC”), an agency within the Department of Health and Human Services (“HHS”), is charged with monitoring the safety of all vaccines, including the COVID-19 vaccines approved by the FDA. The CDC claims that these “COVID-19 vaccines are being administered under the most intensive vaccine safety monitoring effort in U.S. history[.]”
2. The federal government has mandated that millions of Americans receive these vaccine products. HHS has also given pharmaceutical companies complete immunity for injuries caused by those products. Mandating that millions of Americans inject a product for which they cannot hold the manufacturer liable if the product injures them demands complete transparency, especially when it comes to releasing the data underlying the product’s safety. FOIA exists precisely so that the American people can obtain transparency and, in this case, obtain the data which supports the CDC’s claims to intensive safety monitoring.
3. As for the pre-licensure data submitted by the pharmaceutical companies, the FDA took the position in another FOIA action that, because it needs to deidentify that data, it needs at least 75 years to produce the data to the public. As for the post-licensure data, the FDA and CDC have said that their prior primary existing safety monitoring program was incapable of determining causation and were otherwise unreliable. The CDC has, however, deployed a new safety monitoring system for the COVID-19 vaccines, v-safe, and the data within v-safe is already available in deidentified form and could be forthwith released to the public.
4. V-safe is a smartphone app that allows vaccine recipients to “tell CDC about any side effects after getting the COVID-19 vaccine.” The purpose of the app “is to rapidly characterize the safety profile of COVID-19 vaccines when given outside a clinical trial setting and to detect and evaluate clinically important adverse events and safety issues that might impact policy or regulatory decisions.”
5. Data submitted to v-safe is “collected, managed, and housed on a secure server by Oracle,” a private computer technology company. Although the CDC has “access to the individualized survey data,” Oracle can only access “aggregate deidentified data for reporting.”
6. Plaintiff asked through its instant FOIA requests that the CDC produce the deidentified data from the v-safe program in the same form that Oracle can access. Plaintiff believes that to assure transparency regarding the government’s claim that COVID-19 vaccines are “safe and effective,” the public should have immediate access to all v-safe data, in deidentified form, and therefore, once the CDC produces that data, Plaintiff intends to make it publicly available. Despite the fact that the deidentified data already exists, it is already in the hands of a private company, and the CDC has never objected to its production, the CDC has so far failed to produce it to Plaintiff or to the American public. The federal government is thereby not only failing to provide the transparency necessary to earn the American people’s trust regarding these vaccines but is also failing to comply with FOIA.
7. Plaintiff Informed Consent Action Network (“Plaintiff”) is a non-profit organization that advocates for informed consent and full transparency and disseminates information necessary for same with regard to all medical interventions. It intends to make all v-safe data immediately available to the public so that independent scientists can immediately analyze that data. It believes that we need all hands on deck, both inside and outside the government, to address serious and ongoing issues with the vaccine program, including waning immunity, adverse reactions, etc. Locking out independent scientists from addressing these issues is dangerous, irresponsible, unethical, and illegal.
8. To acquire the v-safe data, Plaintiff made three requests to the CDC pursuant to the Freedom of Information Act (5 U.S.C. § 552, as amended) (“FOIA”) seeking information regarding v-safe.
….
You can read the entire complaint here :
December 31, 2021
Posted by aletho |
Civil Liberties, Deception, Science and Pseudo-Science, Timeless or most popular | CDC, COVID-19 Vaccine, FDA, HHS |
Leave a comment